Ibires I 200mg/40mcg Nexcap
By Ibires I
Rx
30 Nexcap in a Packet
Composition
Salbutamol(200mg) + Ipratropium(40mcg)
Manufacturer - Indiabulls pharmaceutical ltd
Indiabulls Pharmaceuticals Limited is M – 62 & 63, First Floor, Connaught Place, New Delhi – 11000
Expires on or after
July, 2025
When using Ibires I 200mg/40mcg Nexcap, it is important to consider the liver's health. As per available information, there have been no interactions established specifically related to liver issues. It is advisable to be cautious if you have existing liver conditions or concerns. Monitoring liver function periodically while using Ibires I 200mg/40mcg Nexcap may be recommended to ensure your liver health is not affected. If you have any doubts or questions regarding how this medication may impact your liver, consult with your healthcare provider for personalized guidance.
No interaction found/established.
Consult your doctor when consuming alcohol with Ibires I 200mg/40mcg Nexcap.
When using Ibires I 200mg/40mcg Nexcap, there is no known interaction that may affect driving.
Ibires I 200mg/40mcg Nexcap may not be safe during pregnancy. Animal studies suggest potential harm to the baby. A doctor will assess the risks and benefits before prescribing. It is important to consult your doctor if pregnant.
Ibires I 200mg/40mcg Nexcap is likely safe when breastfeeding. Limited data shows no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | RESPIRATORY |
Action Class | - |
₹57.13
Inclusive of all taxes
Content verified by
Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 11-Feb-2025